PHARMACOEPIDEM DR S
ISSN：1053-8569 E-ISSN：1099-1557 出版商：Wiley 国家：ENGLAND 周期：Bimonthly
| 收录情况 | h-index：85 CiteScore：4.40 |
The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data| methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research| invited reviews and a variety of guest editorials and commentaries embracing scientific| medical| statistical| legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design| analysis| results| and interpretation of studies looking at the benefit or safety of specific pharmaceuticals| biologics| or medical devices| including studies in pharmacovigilance| postmarketing surveillance| pharmacoeconomics| patient safety| molecular pharmacoepidemiology| or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals| biologics| and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent| diagnose| treat| and monitor a clinical condition| as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology| whether original contributions| reviews of existing methods| or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals| biologics and medical devices.
数据整理自公开网络的投稿反馈，仅供参考。
